baber/WOPTO huggingface dataset:
Patent MX-2019010259-A (MX)
Title: Optical cable with channel structure.
Inventor: CHESTER J KMIEC
IPC: G02B6/44
Filed: 2018-03-16
Abstract: The present disclosure provides an optical cable. In an embodiment, the optical cable includes an elongated member comprising a matrix material and a plurality of channels extending through the matrix material. The optical cable also includes at least one optical fiber extending through at least one channel.
Patent MX-2019012806-A (MX)
Title: Variable coil configuration system control, apparatus and method.
Inventor: JONATHAN GALE RITCHEY
IPC: H02K3/28
Filed: 2018-02-27
Abstract: This application generally relates to electric machines with coils or windings (e.g., generators and motors), and more particularly to systems, apparatus, and methods that configure coils or windings of electric machines, for instance dynamically in response to operational condition and under load.
Patent MX-2020001197-A (MX)
Title: Treatment of cancer by stimulation of il-12 production.
Inventor: MOFFAT DAVID FESTUS CHARLES
IPC: A61P35/00
Filed: 2018-08-30
Abstract: The present invention relates to a compound and composition for use in the stimulation of IL-12 production and IFN-Î³ production, which compound is selected from: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl] -3,5- difluorophenyl}ethyl)-L-alaninate, or a pharmaceutically acceptable salt, hydrate or solvate thereof; and N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl] -3,5- difluorophenyl}ethyl)-L-alanine.
Patent MX-2020001432-A (MX)
Title: Antibodies that bind egfr and cmet.
Inventor: MARK THROSBY
IPC: C07K16/28
Filed: 2018-08-09
Abstract: The invention as disclosed herein relates to bispecific antibodies that comprises a first variable domain that can bind an extracellular part of epidermal growth factor receptor (EGFR) and a second variable domain that can bind an extracellular part of MET Proto-Oncogene, Receptor Tyrosine Kinase (cMET). The antibody may comprise a common light chain, it may be a human antibody, The antibody may be a full length antibody. In some embodiments the bispecific antibody is an IgGl format antibody having an anti-EGFR, anti-eMET stoichiometry of 1:1, In some embodiment the antibody has one variable domain that can bind EGFR and one variable domain that can bind cMET.
Patent MX-2020002520-A (MX)
Title: Method for producing an animal leather substitute and the obtained product.
Inventor: DIAZ TAZZER HERRERIAS DANIEL
IPC: C14C99/00
Filed: 2020-03-05
Abstract: The present invention relates to a method for manufacturing an animal leather substitute based on fungal mycelium. It consists of a) Selecting at least one species of fungi from the families of the polypore order: Ganodermataceae, Polyporaceae, and Fomitopsidaceae, b) Isolate the selected microorganism (by living tissue, spore, mycelium), c) Preparation of Culture Medium based on a technical selection of nutrients to carry out a selective growth of the vegetative body of the fungi called mycelium. Also, it includes d) Inoculate the Culture at a rate of up 10% to 30% of the total volume in a culture reactor, e) Incubate in a culture reactor with control of parameters, such as lighting under a 12/12 hour photoperiod, under a wavelength of up 380nm to 480nm, the temperature of up 22°C to 27°C, relative humidity of up 75% to 95%, agitation with different phases of agitation and a balance between oxygen-carbon dioxide in the range higher than 20,000 ppm CO2 and a retention time of the cult ure of up five days to 45 days. Additionally, it comprises f) harvesting a cover of plant mycelium on the surface of the reactor approximately 3-15 cm thick, g) post-harvest treatment of the mycelium vegetable mat, subjecting it to soaking for between 12 -48 hours and drying in the range of up 40°C to 65°C until it loses 80% of its humidity, and finished.
Patent MX-2020002863-A (MX)
Title: Real time material and velocity control in a molding system.
Inventor: POLLARD RICK ALAN
IPC: B29C45/76
Filed: 2018-09-06
Abstract: A system includes a cavity, an injection nozzle configured to inject material into the cavity, and a plurality of sensors at sensor locations. Each of the plurality of sensors is configured to measure parameters at one of the sensor locations. The system lacks a strain gauge. The system further includes a controller configured to control a flow rate of the injection of material into the cavity. The controller is configured to receive the measured parameters and compare the received information to predetermined curves. The controller is configured to control the flow rate when the measured parameters deviate from the predetermined curves.
Patent MX-2020003951-A (MX)
Inventor: CARLSTEDT SUSANNE
IPC: A61F13/26
Filed: 2017-10-06
Abstract: Un aplicador para un tampón que comprende un tubo interno y un tubo externo, siendo el tubo interno deslizable dentro del tubo externo, teniendo el aplicador un extremo delantero, en donde la superficie interna del tubo externo comprende una protuberancia anular cerca del extremo posterior del tubo externo y el diámetro interno del tubo externo es menor hacia atrás de la protuberancia anular que hacia el frente de la protuberancia anular.
Patent MX-2020004063-A (MX)
Inventor: MOFFETT HOWELL F
IPC: C12N5/0781
Filed: 2018-10-19
Abstract: Se describen sistemas y métodos para modificar genéticamente linfocitos B para que expresen anticuerpos seleccionados. Los sistemas y métodos pueden usarse para: evitar la necesidad de vacunas clásicas; proporcionar protección contra agentes infecciosos para los cuales no hay vacunas disponibles en la actualidad; proporcionar protección contra agentes infecciosos cuando los pacientes se encuentran inmunodeprimidos por otras cuestiones; y/o proporcionar un beneficio proporcionado por un anticuerpo terapéutico, tal como en el tratamiento de trastornos autoinmunitarios.
Patent MX-2020006290-A (MX)
Title: Cyclic dinucleotides as sting agonists.
Inventor: WANG GUANGYI
IPC: A61P31/12
Filed: 2018-12-14
Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein B<sub>2</sub>,X<sub>2</sub>, R<sub>2a</sub>, R<sub>2b</sub>, R<sub>2c,</sub> Z-M-Y, Y<sub>1</sub>-M<sub>1</sub>Z<sub>1</sub>, B<sub>1</sub>, X<sub>1</sub>, R<sub>1a</sub>, R<sub>1b</sub>, R<sub>1c</sub> are as defined herein.
Patent MX-2020006658-A (MX)
Title: Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes.
Inventor: PRESTRELSKI STEVEN
IPC: A61K38/26
Filed: 2018-12-21
Abstract: Certain embodiments are directed to methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia comprising administration to a subject in need thereof a formulation(s) of glucagon or glucagon analog in an amount effective to treat, ameliorate, or prevent the condition. The subject can be administered a glucagon or a glucagon analog composition 1, 5, 10, 15 to 20, 25, 30 minutes prior to initiation of exercise.
Patent MX-2020010404-A (MX)
Title: Method for dissolving metallogenically primary copper metals obtained from ores and/or chalcopyrite concentrates that contain same.
Inventor: CORTÉS CORTÉS RODRIGO ANDRÉS
IPC: C22B3/20
Filed: 2018-04-06
Abstract: The present invention relates to an autocatalytic reductive chemical procedure with solid-solid interaction in conditions of supersaturation of salts, via the phenomenon of efflorescence in order to dissolve a copper metal, from a metallogenically primary ore or chalcopyrite concentrate that contains same. The method comprises two steps, referred to as "Reductive Activation Step" and "Dry Autocatalytic Reductive Transformation Step" or efflorescence, which can be repeated as many times as necessary to maximise the extraction of copper or base metal of interest. The invention can also be used for sulphurised base metals such as nickel, zinc, cobalt, lead and molybdenum, among others, regardless of the common impurities of sulphurised ores, as occurs with the presence of arsenic.
Patent MX-2020011045-A (MX)
Title: Irrigation pipe.
Inventor: MASARWA ABED
IPC: A01G25/02
Filed: 2019-04-21
Abstract: A thin walled irrigating pipe has a tensile layer formed as a continuous strip upon an outer side of the pipe for increasing tensile strength of the pipe. The tensile layer includes a higher tensile strength than material of the remainder of the pipe outside of the tensile layer.
Patent MX-2020013972-A (MX)
Title: Composition for cooling and lubricating a propulsion system of an electric or hybrid vehicle.
Inventor: CHAMPAGNE NICOLAS
IPC: C10M105/38
Filed: 2019-07-02
Abstract: The present invention relates to the use, for cooling and lubricating a propulsion system of an electric or hybrid vehicle, of a composition comprising at least: (i) at least one base oil; and (ii) at least one diester of formula R<sup>a</sup>-C(O)-O-([C(R)<sub>2</sub>]n-O)<sub>s</sub>-C(O)-R <sup>b</sup> (I), different from the base oil (i). The invention also relates to a process for cooling and lubricating a propulsion system of an electric or hybrid vehicle comprising at least one step of bringing at least one mechanical part of said system into contact with a composition as defined above.
Patent MX-2021004012-A (MX)
Title: Her2-binding tetrameric polypeptides.
Inventor: KAST FLORIAN
IPC: A61P35/00
Filed: 2019-10-08
Abstract: The invention relates to a tetrameric polypeptide comprising a first polypeptide chain comprising a first VL antigen binding domain and a first CL constant domain, a second polypeptide chain comprising a first VH antigen binding domain, a first CH1 constant domain, a first CH2 constant domain and a first CH3 constant domain, a first ligand binding to a HER2 D4 epitope linked to the N-terminus of said first VL antigen binding domain or said first VH antigen binding domain by a first interdomain amino acid linker, a third polypeptide chain comprising a second VL antigen binding domain and a second CL constant domain, a fourth polypeptide chain comprising a second VH antigen binding domain, a second CH1 constant domain, a second CH2 constant domain and a second CH3 constant domain and a third ligand binding to a HER2 D4 epitope linked to the N-terminus of said second VL antigen binding domain or said second VH antigen binding domain by a second interdomain amino acid linker, wherein the VL antigen binding domains and the VH antigen binding domains together constitute a second ligand and a fourth ligand binding to a HER2 D1 epitope. The invention further relates to the tetrameric polypeptide for use in a method for the prevention or treatment of a malignant neoplastic disease, an isolated nucleic acid and a host cell for expression of the polypeptide and a method for obtaining the polypeptide.
Patent MX-2021004405-A (MX)
Title: Method and device of treating chronic kidney disease-associated pruritus.
Inventor: VASISHT NIRAJ
IPC: A61K45/06
Filed: 2019-10-17
Abstract: The presently disclosed subject matter is directed to an effective method of treating chronic kidney disease-associated pruritus. Particularly, the method comprises the transmucosal administering of nalmefene to treat chronic kidney disease-associated pruritus, as well as cholestatic pruritus and/or prurigo nodularis. The nalmefene can be configured in a single layer film comprising at least two distinct domains. The film can include a first discrete domain comprising about 50- 100 weight percent polymer matrix and the second discrete domain can comprise the nalmefene or pharmaceutically acceptable nalmefene salt.
Patent MX-2021005645-A (MX)
Title: Prioritized low power neighboring node discovery in an iot network.
Inventor: SINGH SHOBHIT KUMAR
IPC: H04W28/02
Filed: 2019-11-13
Abstract: This disclosure involves neighboring node discovery in a network. For instance, a neighboring node discovery method includes receiving, at a first node, a neighbor solicitation message. The neighbor solicitation message includes an indication that a second node is a low power device and a first scheduled response time. The method also includes transmitting at the scheduled response time, by the first node, a first neighbor advertisement message. The first neighbor advertisement message includes an indication of no availability in a neighbor cache of the first node and a second scheduled respond time. Further, the method includes removing one or more nodes from the neighbor cache, and receiving, at the first node at the second scheduled response time, a second neighbor solicitation message from the second node indicating availability in the neighbor cache. Additionally, the method includes linking the first node and the second node.
Patent MX-2021009593-A (MX)
Title: Glass fiber-reinforced resin molded article.
Inventor: SASAKI RYO
IPC: C03C13/00
Filed: 2020-02-07
Abstract: Provided is a glass fiber-reinforced resin molded article having a low dielectric constant and a low dielectric loss tangent, especially a low dielectric loss tangent, in the high-frequency region of 10 GHz and above. The glass fiber-reinforced resin molded article contains glass fibers in a range of 10-90 mass% and resin in a range of 90-10 mass% relative to the total weight of the glass fiber-reinforced resin molded article. The glass fibers have a composition that includes SiO<sub>2</sub> in a range of 52.0-59.5 mass%, B<sub>2</sub>O<sub>3</sub> in a range of 17.5-25.5 mass%, Al<sub>2</sub>O<sub>3</sub> in a range of 9.0-14.0 mass%, SrO in a range of 0.5-6.0 mass%, MgO in a range of 1.0-5.0 mass%, CaO in a range of 1.0-5.0 mass%, and a total of F<sub>2</sub> and Cl<sub>2</sub> in a range of 0.1-2.5 mass% relative to the total weight of the glass fibers. The glass fibers have a number average fiber length of 1-10,000 Î¼m.
Patent MX-2021010802-A (MX)
Title: Power control circuit for powered surgical stapler.
Inventor: WISE AUSTIN E
IPC: A61B17/115
Filed: 2020-02-26
Abstract: An apparatus (10) includes a body (100), a shaft (200), a stapling assembly (300), and a sequential logic device (8014). The body includes a safety switch (8020), a firing actuator (150, 8016), and a motor (161). The stapling assembly is disposed at a distal end of the shaft, wherein the stapling assembly is configured to selectively move from an open position to a closed position to clamp tissue. The sequential logic device (8014) is operatively coupled with the motor and configured to detect an actuation of the safety switch (8020) and of the firing actuator (8016). The sequential logic device is further operable to detect an order in which the safety switch and the firing actuator are actuated, compare the detected order to a predetermined order, and in response to determining that the detected order is equivalent to the predetermined order, transmit a motor activation signal (8032) to the motor (161).
Patent MX-2021011529-A (MX)
Title: Chiauranib for treatment of small cell lung cancer.
Inventor: PAN DESI
IPC: A61P35/00
Filed: 2020-03-18
Abstract: Disclosed are a method for treating small cell lung cancer by using Chiauranib and the use of Chiauranib in the preparation of a drug for treating small cell lung cancer.
Patent MX-2021012338-A (MX)
Title: User control device for a transporter.
Inventor: KAMEN DEAN
IPC: A61G5/06
Filed: 2018-10-12
Abstract: A user control device for a transporter. The user control device can communicate with the transporter via electrical interface(s) that can facilitate communication and data processing among the user interface device and controllers that can control the movement of the transporter. The user control device can perform automated actions based on the environment in which the transporter operates and the user's desired movement of the transporter. External applications can enable monitoring and control of the transporter.
Patent MX-2022000828-A (MX)
Title: Method and generator for characterizing an oscillatory system.
Inventor: ERTZ GABRIEL
IPC: G01R27/26
Filed: 2020-07-15
Abstract: The present invention relates to a method for determining at least one physical characteristic value of an electromechanical oscillatory system, which comprises a piezoelectric element (10) and at least one additional element, the at least one additional element being coupled, with respect to oscillation, to the piezoelectric element (10), the piezoelectric element (10) having an electrode and a counter electrode. The method comprises the following steps: (a) applying an alternating voltage between the electrode and the counter electrode for the duration of an excitation interval in order to induce mechanical oscillation of the oscillatory system or of a sub-system of the oscillatory system by excitation, such that, after the excitation interval has expired, the oscillatory system or the sub-system performs free oscillation without excitation, (b) after the end of the excitation and during the free oscillation of the oscillatory system or of the sub-system without excitation: (i) measuring the time curve of a voltage U between the electrode and the counter electrode, or (ii) short-circuiting the electrode and the counter electrode with a line (28) and measuring the time curve of a current I through the line (28), and (c) determining the at least one physical characteristic value of the electromechanical oscillatory system from the time curve of the voltage U, which time curve was measured in step b) i), or from the time curve of the current I, which time curve was measured in step b) ii).
Patent MX-2022002835-A (MX)
Title: Laminated glass interlayer, and laminated glass.
Inventor: MAEDA SATOSHI
IPC: C03C27/12
Filed: 2020-12-09
Abstract: A laminated glass interlayer having a structure including one or more layers, the laminated glass interlayer being provided with a first layer that includes a thermoplastic resin and silica particles, the silica particles havving an average secondary particle diameter (d50) of 0.01-2.2 Î¼m (inclusive), and the maximum grain diameter peak value is 20 Î¼m or lower.
Patent MX-2022003211-A (MX)
Title: Dialysis system and machine having therapy prescription recall.
Inventor: YU ANPING
IPC: G16H20/10
Filed: 2011-01-07
Abstract: In one embodiment an automated peritoneal dialysis ("APD") machine (104) includes: at least one pump; a logic implementer storing a plurality of therapy prescriptions by which to operate the at least one pump, each therapy prescription pre-approved for a particular patient; and an input device (160) operating with the logic implementer to allow the patient to select one of the therapy prescriptions for a particular therapy. In another embodiment, the input device operating with the logic implementer allows a doctor/clinician to select or approve one of the therapy prescriptions to be run on the APD machine. In a further embodiment, the logic implementer is programmed to select or suggest one of the therapy prescriptions to be run on the is APD machine.
Patent MX-2022003357-A (MX)
Title: Combination anti-cd30 adc, anti-pd-1 and chemotherapeutic for treatment of hematopoietic cancers.
Inventor: MANLEY THOMAS
IPC: A61K39/395
Filed: 2020-09-25
Abstract: The present disclosure relates, in general to methods for treating hematologic cancers comprising administering an anti-CD30 antibody drug conjugate in combination with additional cancer therapeutics such as a checkpoint inhibitor, and a chemotherapeutic regimen.
Patent MX-2022004670-A (MX)
Title: High-strength steel sheet and production method therefor.
Inventor: TOJI YUKI
IPC: C22C38/00
Filed: 2020-10-08
Abstract: This high-strength steel sheet is characterized by having a predetermined component composition, and a steel structure in which the area percentage of ferrite is 30-80%, the area percentage of martensite is 5-35%, the area percentage of residual austenite is 8% or more, the value obtained by dividing the area percentage of residual austenite having an aspect ratio of 2.0 or more and a minor axis of 1 Î¼m or less by the area percentage of the entire residual austenite is 0.3 or more, the value obtained by dividing the average Mn content (mass%) of the residual austenite by the average Mn content (mass%) of the ferrite is 1.5 or more, and the value obtained by multiplying, by the average aspect ratio of the residual austenite, the value obtained by dividing the average Mn content (mass%) of the residual austenite by the average Mn content (mass%) of the ferrite is 3.0 or more, the value obtained by dividing the average C content (mass%) of the residual austenite by the average C content (mass%) of the ferrite is 3.0 or more, and the value obtained by dividing the average C content (mass%) of the residual austenite by the average Mn content (mass%) of the residual austenite is less than 0.05.
Patent MX-2022006363-A (MX)
Title: Process for preparing oligo ethylene glycol methyl ether borate.
Inventor: WERTH KATHRIN LUISE MARIETHRES
IPC: C07F5/04
Filed: 2020-11-19
Abstract: The present invention relates to a process for preparing oligo ethylene glycol methyl ether borate comprising the steps of: a) feeding boric acid and oligo ethylene glycol monomethyl ether into a reactor (10) and reacting the resulting mixture to obtain a raw product which comprises oligo ethylene glycol methyl ether borate, water and unreacted boric acid and oligo ethylene glycol monomethyl ether; b) feeding the raw product to a reactive distillation device (30) and reacting boric acid with oligo ethylene glycol monomethyl ether to full conversion of boric acid; c) transferring a distillate stream containing water from the top of the reactive distillation device (30) to a condenser (34) and recycling a condensed liquid stream to the top of the reactive distillation device (30); and d) withdrawing a bottom product stream containing oligo ethylene glycol methyl ether borate from the reactive distillation device (30), transferring part of the bottom product stream to a reboiler (33) and recycling the resulting vapor stream to the bottom section of the reactive distillation device (30).
Patent MX-2022007403-A (MX)
Title: Management and control system for a parking lot.
Inventor: BERTO RENATO
IPC: G07B15/02
Filed: 2020-12-17
Abstract: A management and control system for a parking lot provided with a first sub-system including all the parking terminals of the parking lot, a second sub-system including at least one parking controller associated to and adapted to manage and overview the parking terminals of the parking lot, and a third sub-system comprising a remote server and a remote data base associated to said parking controller and said parking terminals through a connection network. The management and control system is further provided with means for collecting the relevant data and information from said parking terminals and for storing said relevant data and information in the remote database, making it available for maintenance purposes and for initial settings of the replacement terminal modules.
Patent MX-2022010798-A (MX)
Title: High strength cold rolled and galvannealed steel sheet and manufacturing process thereof.
Inventor: DRILLET JOSÉE
IPC: C21D8/02
Filed: 2021-02-08
Abstract: The invention deals with a cold rolled and galvannealed steel sheet having a composition comprising, by weight percent: C 0.15-0.25%, Mn 2.4-3.5%, Si 0.30-0.90%, Cr 0.30-0.70%, Mo 0.05-0.35%, Al 0.001-0.09%, Ti 0.01-0.06, B 0.0010-0.0040%, Nb 0.01 -0.05%, Pâ¤0.020%, Sâ¤0.010% and Nâ¤0.008%, the remainder of the composition being iron and unavoidable impurities resulting from the smelting, and having a microstructure consisting of, in surface fraction, between 80% and 90% of martensite, the balance being ferrite and bainite.